← Back to Search

Chronic care management for Tobacco Smoking (POST Trial)

Phase 3
Waitlist Available
Research Sponsored by Hennepin Healthcare Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post baseline
Awards & highlights

POST Trial Summary

This trial is testing two different ways to help people with mental illness quit smoking. It will compare how well they work compared to usual care.

Eligible Conditions
  • Tobacco Smoking
  • Mental Health Disorders

POST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Cigarettes per day
Quit attempts
Smoking abstinence

POST Trial Design

1Treatment groups
Experimental Treatment
Group I: Chronic care for tobacco useExperimental Treatment1 Intervention
Quarterly brief provider interventions about tobacco and 3 quarterly proactive outreach calls to connect patients to telephone cessation counseling and facilitate obtaining cessation medication.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chronic care management
2021
Completed Phase 3
~50

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor
90 Previous Clinical Trials
77,128 Total Patients Enrolled
Brown UniversityOTHER
456 Previous Clinical Trials
558,267 Total Patients Enrolled
University of MinnesotaOTHER
1,381 Previous Clinical Trials
1,551,235 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA cleared chronic care management?

"There is some efficacy data and multiple rounds of safety data, making it a Phase 3 trial, and thus estimated to be a 3 in terms of safety."

Answered by AI

Who else is applying?

What state do they live in?
Wisconsin
How old are they?
18 - 65
What site did they apply to?
Hennepin Healthcare Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Hennepin Healthcare Research Institute: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
clinicaltrials.govStudy
Proactive Outreach for Smoking Treatment
2021. "Proactive Outreach for Smoking Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04988477.
~13 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top